All articles by Vidya Sagar Maddela
Vidya Sagar Maddela
Roche secures FDA approval, CLIA waiver for cobas liat STI test
The cobas liat STI panels include tests for chlamydia and gonorrhea (CT/NG) and chlamydia, gonorrhea, and Mycoplasma genitalium (CT/NG/MG), which run on Roche’s cobas liat system
Abbott Laboratories’ Q4 2024 net income increases to $9.23bn
The US-based medical device company reported net sales of $10.97bn for Q4 2024, a 7.2% rise compared to $10.24bn for the same period in 2023, and a 3.5% increase compared to $10.6bn for Q3 2024
Inflammatix secures FDA approval for TriVerity test system
TriVerity is a rapid diagnostic test designed to measure the expression levels of 29 genes associated with the host’s immune response to infection and leverages validated AI/ML algorithms to interpret the host response
Clarius unveils new advancements in ultrasound software
Clarius offers a range of AI-powered speciality ultrasound scanners designed to deliver high-definition imaging for diverse clinical applications, with imaging quality that matches the traditional cart-based systems
IntelliGenome Receives FDA Breakthrough Device Designation for CRISPR-TB Blood Test
This test is the first qualitative real-time polymerase chain reaction (PCR) assay to combine CRISPR technology, designed to detect Mycobacterium tuberculosis (Mtb) cell-free DNA in human serum and EDTA plasma.
Motif Neurotech secures UK’s ARIA funding to advance its BCI technology
The funding, which forms part of ARIA’s Precision Neurotechnologies programme, will help the US-based company create neural devices to monitor and regulate mental and cognitive states without brain surgery
HKUST researchers develop multifunctional biomedical robot
The biomedical robot, which is 60% smaller than current models and comes with a 0.95mm slim profile, provides competitive imaging performance and an improved obstacle detection distance of up to 9.4 mm
MicroAire Completes Acquisition of NEOSYAD
This strategic move reinforces MicroAire’s commitment to advancing medical innovation and strengthening its leadership in the adipose tissue market.
MediBeacon gets FDA nod for TGFR System to assess kidney function
The Transdermal GFR System (TGFR) enables point-of-care assessment of kidney function in patients with normal or impaired renal function across the adult population without input of age, weight, sex, gender, race, or ethnicity
NAMSA acquires WuXi AppTecs’s US medical device testing business
NAMSA will acquire WuXi AppTec’s medical device testing facilities in Minnesota and Georgia, with all other Contract Research, Development, and Manufacturing Organisation (CRDMO) operations remaining unaffected